375
Views
0
CrossRef citations to date
0
Altmetric
Editorial

The cardiovascular safety of sodium nitroprusside in acute heart failure

, , , &
Pages 663-666 | Received 13 Jan 2024, Accepted 24 Apr 2024, Published online: 29 Apr 2024

Figures & data

Figure 1. Efficacy of sodium nitroprusside according to different cardiac phenotypes and its effects on pressure-volume loops. In the upper panels the gray loop depicts basal conditions, and the black loop represents the alterations induced by sodium nitroprusside. In the lower part of the figure the gray curve indicates left ventricular end-diastolic diameter, and the black curve represents left ventricular ejection fraction.Adv: advanced; ea: arterial elastance; HFpEF: heart failure with preserved ejection fraction; HFrEF: heart failure with reduced ejection fraction; LV: left ventricular; LVEDD: left ventricular end-diastolic diameter; LVEF: left ventricular ejection fraction; MR: mitral regurgitation; P: pressure; SNP: sodium nitroprusside; SV: stroke volume; VA: ventriculo-arterial.

Figure 1. Efficacy of sodium nitroprusside according to different cardiac phenotypes and its effects on pressure-volume loops. In the upper panels the gray loop depicts basal conditions, and the black loop represents the alterations induced by sodium nitroprusside. In the lower part of the figure the gray curve indicates left ventricular end-diastolic diameter, and the black curve represents left ventricular ejection fraction.Adv: advanced; ea: arterial elastance; HFpEF: heart failure with preserved ejection fraction; HFrEF: heart failure with reduced ejection fraction; LV: left ventricular; LVEDD: left ventricular end-diastolic diameter; LVEF: left ventricular ejection fraction; MR: mitral regurgitation; P: pressure; SNP: sodium nitroprusside; SV: stroke volume; VA: ventriculo-arterial.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.